<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>MS 1996 num. 11</title>
<link>http://hdl.handle.net/10608/234</link>
<description/>
<pubDate>Wed, 22 Apr 2026 18:12:39 GMT</pubDate>
<dc:date>2026-04-22T18:12:39Z</dc:date>
<image>
<title>MS 1996 num. 11</title>
<url>http://www.ipubli.inserm.fr:80/bitstream/id/29168/</url>
<link>http://hdl.handle.net/10608/234</link>
</image>
<item>
<title>La génétique de la stérilité masculine</title>
<link>http://hdl.handle.net/10608/672</link>
<description>La génétique de la stérilité masculine
Bourgeron, T; Barbaux, S; McElreavey, K; Fellous, M
About 15 % of couples world wide are affected by sterility problems. A substantial genetic component in male infertility is indicated by familial cases and de novo chromosomal rearrangements associated with the phenotype. Relatively  little research has focused on the genetic aetiology of this frequent problem, whose the genetic causes are thus still unknown. Recent progress in understanding the genetics of meiosis in other organisms such as yeast and mice may permit the isolation of  human homologous genes involved in this process. In this respect a number of homozygous null mutant mice (" knockout " mice) have been described where the only phenotypic abnormality is an absence of spermatogenesis. These genes represent excellent  candidates for human male idiopathic infertility. Surprisingly, no gene mutations have been described in man that cause only a defect in spermatogenesis. A better understanding of the genetics of spermatogenesis should provide simple procedures to  evaluate potential male carriers prior to expensive assisted reproductive techniques. It should also provide a knowledge-based approach to the management and treatment of male infertility. Such information should allow the development of effective  fertility treatments, possibly through gene therapy, and of novel, reversible, male contraceptives.
</description>
<pubDate>Mon, 01 Jan 1996 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10608/672</guid>
<dc:date>1996-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Brèves</title>
<link>http://hdl.handle.net/10608/673</link>
<description>Brèves
</description>
<pubDate>Mon, 01 Jan 1996 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10608/673</guid>
<dc:date>1996-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Le déclin du français médical en Europe et aux Etats-Unis</title>
<link>http://hdl.handle.net/10608/670</link>
<description>Le déclin du français médical en Europe et aux Etats-Unis
Navarro, F
</description>
<pubDate>Mon, 01 Jan 1996 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10608/670</guid>
<dc:date>1996-01-01T00:00:00Z</dc:date>
</item>
<item>
<title>Médecine à Peter C. Doherty et Rolf M Zinkernagel. La restriction de la réponse immunitaire par le complexe majeur d'histocompatibilité</title>
<link>http://hdl.handle.net/10608/671</link>
<description>Médecine à Peter C. Doherty et Rolf M Zinkernagel. La restriction de la réponse immunitaire par le complexe majeur d'histocompatibilité
Lotteau, V
</description>
<pubDate>Mon, 01 Jan 1996 00:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10608/671</guid>
<dc:date>1996-01-01T00:00:00Z</dc:date>
</item>
</channel>
</rss>
